Latest Articles and Analysis

On April 1, Taylor Swift dropped a surprise music video for her song "Elizabeth Taylor," directing streaming royalties to the Elizabeth Taylor AIDS Foundation (ETAF). Two weeks earlier, on March 18,...

Public health programs like 340B are designed with a clear and urgent purpose: to improve community health, expand access to care, and protect the most vulnerable among us. Whether it’s ensuring...

New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

Rising employer premiums averaging 9.5% erode wages, forcing workers to delay care.

CROI 2026 showcased breakthroughs alongside funding crisis disrupting global and domestic HIV services.

ADAPs achieve 87% viral suppression but face funding crisis as multiple policies erode 340B rebates.

Break Up Big Medicine Act would force structural separation of insurers, PBMs, and pharmacies.

Medicare drug negotiation's third wave includes Biktarvy, raising HIV treatment access concerns.

Administration expands OUD medication access while defunding SAMHSA and restricting harm reduction.

FY2026 preserves HIV funding but level funding can't support long-acting therapeutics or growing needs.

Q1 2026 Watch: HCV/HIV co-infection treatment access under evolving federal and state policies.

Florida ADAP cuts eligibility from 400% to 130% FPL, threatening 16,000 PLWHA.

340B program drifted from patient benefit; federal reform needed for transparency and accountability.

Enhanced ACA subsidies expired Jan 1; Senate framework proposes two-year extension with restrictions.

CANN marks 30th anniversary with expanded partnerships and cross-condition advocacy evolution.

Lupus Colorado partnership with CANN demonstrates how disease-specific and multi-condition advocates amplify healthcare policy impact.

2025 healthcare crises result from policy choices as ACA subsidies expire, HIV care deteriorates, and state pricing experiments proliferate.

World AIDS Day honors resilience of HIV advocates and communities resisting policy failures and system barriers to care.

Personal narrative on becoming an HIV advocate and the gratitude found in fighting for healthcare access from lived experience.